StockGuru Shines its Spotlight on Amarantus Biosciences, Inc. (OTCBB: AMBS) As It Announces Close of Convertible Bridge Note — October 11, 2011

by editor | Oct 11, 2011 | Latest Spotlights, Medical Stocks

(Dallas, TX. – October 11, 2011) StockGuru Shines its Spotlight on Amarantus Biosciences, Inc. (OTCBB: AMBS).  Amarantus is a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell...

StockGuru Shines its Spotlight on Amarantus BioSciences, Inc. (OTCBB: AMBS) As It Retains Danny Lee for Corporate Development – September 22, 2011

by editor | Sep 22, 2011 | Latest Spotlights, Medical Stocks

(Dallas, TX. – September 22, 2011) StockGuru Shines its Spotlight on  Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death...

StockGuru Shines its Spotlight on Amarantus BioSciences, Inc. (OTCBB: AMBS) Amarantus BioSciences Presents Summary of Peer-Reviewed Data for Parkinson’s Program – August 3, 2011

by editor | Aug 3, 2011 | Latest Spotlights, Medical Stocks

Scientific Literature Provides Compelling Rationale for Further Development Dallas, Texas (August 3, 2011) – StockGuru shines its Spotlight on Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying...

StockGuru Shines its Spotlight on Amarantus BioSciences, Inc. (OTCBB: AMBS) Biotechnology Company Focused on Cell Death Known as Apoptosis – July 27, 2011

by editor | Jul 27, 2011 | Latest Spotlights, Medical Stocks

Dallas, Texas (July 27, 2011) – StockGuru shines its Spotlight on Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death known as...